Report Categories
View AllRecent Articles
View All
Is Expensify Exfy Stock A Growth Play Price At 0.78 Down 0.52 20260410
Is Vizsla Vzla Stock A Growth Play Price At 3.27 Up 0.77 20260413
Can Avista Ava Stock Beat Estimates Price At 41.24 Down 0.24 20260406
Daily Market Overview S P 500 Nasdaq Edge Higher Dow Slips 0.18 Pct In Mixed Trade 20260408 1
Can First FFA stock keep rising today FFA Earnings First reports no EPS or revenue no consensus estimates published
Is Rocky Brands RCKY stock priced attractively Technical Weakness 20260420
Adagio Med ADGM Stock Technical Outlook Weakens 20260422
USChina Frontier AI Competition and Tech Policy Update
Xi Warns Trump Mishandling Taiwan Could Strain USChina Relations Markets on Alert
cbdMD YCBD Q1 2026 Miss What Went Wrong
Manappuram Finance and Apollo Micro Systems Show Bullish Technical Breakouts Amid Nifty Consolidation
Zymeworks ZYME Q1 2026 Results Miss Estimates EPS 059 vs 020
GlobalFoundries Strong Q1 Performance Signals Growth Inflection Say Meridian Fund Managers
HRS Aluglaze Shares Surge 6 After Strong Q4 FY26 Results Revenue Up 60 Profit Nearly Doubles
SpaceX Scrubs Starship Test Flight Sets Friday for Next Attempt Amid IPO Prospectus Release
Evercore ISI Raises Price Target on Cummins Inc CMI
Portugals Meo Sues State for 82 Million Over Huawei 5G Ban
Dhoot Transmission Files Updated DRHP for 1400 Crore IPO with Sebi
GHRS Q1 2026 Earnings WiderthanExpected Loss Underscores ClinicalStage Challenges
MCO Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline
JBS Q1 2026 Earnings EPS Miss Drags on Stock Despite Resilient Operations
Genmab AS ADS GMAB Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Picture Remains Unclear
MTA Q1 2026 Earnings EPS Falls Short of Estimates Amid Tough Comparisons
AgEagle Aerial Systems UAVS Q3 2023 Earnings Narrowing Losses Amid Strategic Pivot
ENvue Medical FEED Surges 86 as Stock Tests Key Resistance at 106
StandardAero Inc SARO Surges 241 as Shares Approach Key Resistance Level
Xenetic Biosciences XBIO Modestly Advances as Biotech Stock Tests Key Resistance Zone
Incyte Corp INCY Edges Lower as Stock Consolidates Near Key Levels
Calamos Convertible and High Income Fund CHY Edges Higher Amid Steady Support Levels